You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

December 7, 2023

Hague Design Applications in Vietnam Still Face Issues

Managing Intellectual Property

The Hague Agreement Concerning the International Registration of Industrial Designs (the Hague Agreement) officially took effect in Vietnam on December 30, 2019. Since then the Hague Express Database reports that more than 1,300 international design applications have designated Vietnam, and many of them have been examined by Vietnam’s IP Office before a statement of grant of protection was issued. However, from the time the Hague Agreement took effect until the amended Intellectual Property Law took effect on January 1, 2023, there were no legal documents regulating the process and procedures for examining these applications in Vietnam. This caused some difficulties in the examination process and many applications filed from 2020 to date remain in limbo, with the applicants having submitted responses to refusals, but yet to receive further results on the grant or refusal of protection.

The amended IP Law introduced Article 93.9 on the validity of international registrations of industrial designs according to the Hague Agreement. More recently, Decree 65/2023/ND-CP (Decree 65) introduced a new section on the filing and processing of Hague international design applications, with detailed regulations on the handling of Hague applications originating in Vietnam and Hague applications designating Vietnam. These new regulations have generally improved the international application process in Vietnam for both the IP Office and design applicants; however, they have not resolved some existing problems and in some cases have created more burdens for applicants.

Submission of priority documents

Article 24.8 of Decree 65 requires that within three months from the date of the International Bureau’s notification of the Hague Application designating Vietnam, applicants wishing to benefit from a priority must submit documents proving their priority right to the IP Office for approval. This is a completely new requirement that applies to all international design applications designating Vietnam starting from the effective date of Decree 65 (August 23, 2023).

Generally, communication between the IP Office and foreign applicants must be intermediated by an IP agent. As Vietnam currently does not accept electronic priority documents or participate in WIPO’s Digital Access Service (DAS) system, applicants must work with local IP agents to prepare priority documents in paper form and submit them directly at the IP Office. This is a new burden for applicants as they previously only needed to work with the local agent when the application was rejected. In practice, the statutory time limit of three months cannot be extended, and the procedure for receiving priority documents at the IP Office requires clearly indicating the Vietnamese application number corresponding to the international design application. This has caused difficulties for applicants and IP agents, as checking the Vietnamese application number assigned to the international design application is inconvenient.

Unclear regulations on powers of attorney

Though transactions between the IP Office and foreign applicants normally need to go through a local agent, there are no specific regulations on the submission of powers of attorney when the applicant wants to submit priority documents or a response to a notification of refusal for a Hague design application. Currently, the applicant’s responses are all filed via a local agent and are accompanied by a power of attorney. However, the deadline for submitting the power of attorney is unclear, as is the possibility of any deadline extension, creating further challenges.

Processing time after response to notification of refusal

Articles 24.6 and 24.7 of Decree 65 stipulate that, if the applicant’s corrections of defects and/or responses are acceptable, the IP Office will issue a statement of grant of protection. If a three-month period passes without an acceptable response/correction from the applicant, the IP Office will issue a decision to refuse protection. However, there is no regulation on the time limit for the IP Office to provide this further communication. Currently, many applicants have responded to notifications of refusals without receiving any subsequent notification/decision from the IP Office. This makes the applicants uncertain about whether their applications will be protected in Vietnam, and when the registration procedure will actually be completed.

Reproductions of designs accepted for protection are not published

Decree 65 sets out that the IP Office’s statement of grant of protection is to be published in the Industrial Property Gazette within two months from the date of the statement. However, it is unclear whether reproductions of the designs accepted for protection will also be published. Specifically, the content accepted for protection after amendments may not be accessible. We believe that reproductions of designs accepted for protection need to be published and included in the online database of the IP Office to facilitate the public’s access and searches for information.

Other issues

The current regulations do not provide a procedure for voluntary amendments of international designs, (such as amending the descriptions or drawings), assignments, or changes made only for the national phase in Vietnam. In addition, although requirements for industrial design specifications have been reduced under the amended IP Law, they are still not in line with the requirements in other countries. This leads to objections to many specifications of international design applications when entering the national phase in Vietnam; the new regulations are not as favorable for applicants as expected.

As IP practitioners, we hope that the upcoming circular of the Ministry of Science and Technology on industrial property (expected to be issued within December 2023) and the IP Office’s guidelines on industrial design examination will be adjusted to provide a legal basis to resolve the above issues.

This article first appeared in Managing Intellectual Property.

RELATED INSIGHTS​ 

July 30, 2025
Artificial intelligence (AI) model training and data scraping are essential processes in the development of modern AI systems. AI model training involves using large datasets to teach machine learning algorithms to recognize patterns, make predictions, or generate new content. Data scraping refers to the automated extraction of information from websites or digital sources, often to assemble the vast datasets required for effective AI training. As these practices become more widespread, questions about the legality of using third-party content—especially copyrighted works—have become increasingly important. In Thailand, the legal landscape for AI developers is shaped primarily by the Copyright Act, which presents unique challenges due to the absence of a fair-use exception. This article examines the copyright-related risks and legal uncertainties facing AI developers under Thailand’s current copyright law and practices, offering strategic guidance for navigating this complex environment. Copyright Risks in AI Scraping and Training Thailand’s Copyright Act does not provide a broad fair use or fair dealing exception, unlike some other jurisdictions, such as the United States. This absence has significant consequences for AI developers: No general defense for AI training: Any use of copyrighted material for AI model training is presumed to be infringing unless a specific, narrow statutory exception applies or explicit permission is obtained from the rights holder. There is no general legal basis for using copyrighted works in AI training without authorization. Increased rights clearance burden: Developers must identify and secure licenses for every copyrighted work included in their training datasets. Given the scale and diversity of data required for effective AI models, this process can be both impractical and costly. Legal ambiguity and litigation risk: The lack of clear statutory guidance or case law leaves developers in a legal gray area. There is no established precedent clarifying whether certain uses of copyrighted material for
July 25, 2025
Over the first half of 2025, the government of Vietnam has implemented a comprehensive suite of legislative reforms that significantly impact the country’s intellectual property (IP) framework. These amendments, most of which took effect on 1 July 2025, span the criminal, civil, administrative, and judicial sectors, and are part of a broader initiative to modernize Vietnam’s legal infrastructure, strengthen enforcement mechanisms, and harmonize domestic regulations with international standards. A summary of the key legislative changes and their potential implications for IP protection and enforcement across Vietnam is provided below. Criminal Code: Stricter penalties Under the 2025 amendments to Vietnam’s Criminal Code, penalties for offenses involving the manufacturing and trading of counterfeit goods have been significantly escalated. Individuals convicted of such violations now face fines ranging from VND 200 million to VND 2 billion (approximately USD 7,700 to USD 77,000; up from VND 100 million to VND 1 billion). For corporate entities, the penalties are even more severe, with fines ranging from VND 2 billion to VND 40 billion (roughly USD 77,000 to USD 1.54 million; up from VND 1 billion to VND 20 billion). These heightened penalties reflect the government’s intensified efforts to deter counterfeit-related crimes and protect consumer rights. Law on Handling Administrative Violations: Extended statute of limitations and application of electronic procedure The statute of limitations for addressing administrative violations in the IP sector is still two years. However, in cases where such violations are referred by procedural authorities, this period is extended by one year. The time taken by these authorities to process the case is now included within the overall limitation period. In addition, the Law on Handling Administrative Violations facilitates the use of electronic procedures, provided that the necessary infrastructure, technical systems, and information conditions are in place. Specifically, enforcement authorities are now permitted
July 21, 2025
Distinctiveness is a fundamental requirement for a trademark’s registration and protection under Thai law. The Thai courts typically assess distinctiveness based on a mark’s inherent characteristics rather than its use, as proving acquired distinctiveness through use requires substantial evidence, including the duration of use, extent of distribution and promotional efforts. However, the Intellectual Property and International Trade Court (IP & IT Court) has recently ruled that the figurative mark WEPLAY had acquired distinctiveness through use – an uncommon ruling under Thai trademark law. Subsequently, the Court of Appeal for Specialised Cases affirmed the mark’s inherent distinctiveness based on a holistic assessment of its components. This article discusses the criteria for proving both inherent and acquired distinctiveness, offering examples from both courts to provide valuable insights into case preparation and understanding of how the courts assess distinctiveness. Background In 2017 the plaintiff filed a trademark application for the mark depicted below for goods in Class 28, including toy building blocks: The registrar rejected the application on the grounds of non-distinctiveness under Section 7 of the Trademark Act. The plaintiff appealed to the Board of Trademarks, which considered that, when the term ‘weplay’ is used for goods in Class 28, it is descriptive of the nature of the goods applied for as “playthings”. Therefore, ‘weplay’ was deemed nondistinctive under Section 7, Paragraph 2(2) of the Trademark Act. IP & IT Court decision In 2024 the IP & IT Court ruled that the term ‘weplay’ is not a coined or invented word; instead, it is a combination of ‘we’ and ‘play’, conveying the meaning of ‘we play’. When the term is used for goods in Class 28, it describes the nature of the goods as “playthings”. Consequently, the mark was deemed non-distinctive. However, the court considered the evidence presented by the plaintiff,
July 14, 2025
Life sciences specialists from Tilleke & Gibbins have updated the firm’s guide to pharmaceutical data exclusivity regulations and practices in Southeast Asia. This guide contains quick-reference information on the availability of data exclusivity protections and limitations in Cambodia, Indonesia, Laos, Malaysia, Myanmar, Thailand, and Vietnam. Developing and launching a new drug on a commercial scale requires an enormous amount of time and investment in research and development (R&D), including pre-clinical testing and clinical trials. When considering the aggregate amount of drug development costs, it is important to recognize that this includes not only the investment in developing new drugs that get approved by a government food and drug regulator and are successfully brought to market, but also the R&D expenditures on a large number of potential pharmaceutical compounds and products that never actually make it to market. In particular, considerable investment is required in order to conduct and produce clinical trial data—to prove safety, efficacy and effectiveness of a new drug—that would warrant marketing approval by the regulatory authority. Such data is proprietary in nature and highly valuable for a research-based pharmaceutical company that develops an original drug. On the other hand, patent law typically confers generic drug manufacturers with the ability to engage in various preparatory activities with a view to obtaining marketing approval for a generic product before the patent for the original drug expires (commonly known as a “Bolar provision”). Since a generic drug maker may submit an application for marketing approval of a generic product before the relevant patent expires, the extent to which the drug originator’s data submitted to the regulatory authority is protected—or in other words, the extent to which the generic company may rely on the drug originator’s previously filed data, which underpins the safety and efficacy of the drug, to support